SGLT2 inhibition: a new era in renoprotective medicine?

Marcel H. A. Muskiet; Hiddo J. L. Heerspink; Daniel H. van Raalte

doi:10.1016/S2213-8587(17)30222-X

SGLT2 inhibition: a new era in renoprotective medicine?

Marcel H. A. Muskiet^*
, Hiddo J. L. Heerspink
, Daniel H. van Raalte

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

7 Citations (Scopus)

83 Downloads (Pure)

Original language	English
Pages (from-to)	569-571
Number of pages	3
Journal	Lancet Diabetes & Endocrinology
Volume	5
Issue number	8
DOIs	https://doi.org/10.1016/S2213-8587(17)30222-X
Publication status	Published - Aug-2017

Keywords

MECHANISMS

Access to Document

10.1016/S2213-8587(17)30222-X

SGLT2 inhibition a new era in renoprotective medicineFinal publisher's version, 164 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{577f43c45ca749d48d8d45d2a23e38c8,

title = "SGLT2 inhibition: a new era in renoprotective medicine?",

keywords = "MECHANISMS",

author = "Muskiet, \{Marcel H. A.\} and Heerspink, \{Hiddo J. L.\} and \{van Raalte\}, \{Daniel H.\}",

year = "2017",

month = aug,

doi = "10.1016/S2213-8587(17)30222-X",

language = "English",

volume = "5",

pages = "569--571",

journal = "Lancet Diabetes \& Endocrinology",

issn = "2213-8587",

publisher = "ELSEVIER SCIENCE INC",

number = "8",

}

TY - JOUR

T1 - SGLT2 inhibition

T2 - a new era in renoprotective medicine?

AU - Muskiet, Marcel H. A.

AU - Heerspink, Hiddo J. L.

AU - van Raalte, Daniel H.

PY - 2017/8

Y1 - 2017/8

KW - MECHANISMS

U2 - 10.1016/S2213-8587(17)30222-X

DO - 10.1016/S2213-8587(17)30222-X

M3 - Comment/Letter to the editor

C2 - 28666776

SN - 2213-8587

VL - 5

SP - 569

EP - 571

JO - Lancet Diabetes & Endocrinology

JF - Lancet Diabetes & Endocrinology

IS - 8

ER -